Related Experiment Video
Updated: Jan 27, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
A Multifactor Approach to Mild Cognitive Impairment
1Department of Neurology, Yale School of Medicine, Yale University, New Haven, Connecticut.
Abstract:
Mild cognitive impairment (MCI) represents an intermediate stage between normal cognition and dementia. Individuals with MCI are at increased risk of conversion to dementia, and the rate of progression of MCI to dementia is dependent on age, gender, and education. MCI may be diagnosed using neuropsychological criteria using cut-offs representing decrements in cognition, or using criteria to assess for a decline in functional status. The ability to determine the status of dementia-related biomarkers has allowed for better staging and prognostication in different forms of MCI. MCI is now recognized as a significant target stage for future therapies. These future therapies aim to reduce the rate of conversion of individuals with MCI to dementia. In this article, we review different conceptions of MCI, the diagnosis and prognostication of MCI, and presently available management approaches for this condition.
Insights
Mild cognitive impairment (MCI) is a stage between normal cognition and dementia. Early diagnosis and management of MCI are crucial for potentially slowing progression to dementia.
Area of Science:
- Neurology
- Gerontology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) signifies an intermediate phase between normal cognitive function and dementia.
- Individuals with MCI face an elevated risk of progressing to dementia, with progression rates influenced by factors like age, gender, and education.
Purpose of the Study:
- To review current understanding of MCI, including its various conceptions.
- To discuss diagnostic and prognostic methods for MCI.
- To outline existing management strategies for MCI.
Main Methods:
- Neuropsychological criteria and functional status assessments are used for MCI diagnosis.
- Advancements in dementia-related biomarker assessment aid in MCI staging and prognostication.
Main Results:
- MCI diagnosis can be based on cognitive decrements or decline in functional status.
- Biomarker analysis improves the accuracy of MCI staging and predicting dementia conversion.
Conclusions:
- MCI is a critical stage for therapeutic intervention aimed at reducing dementia conversion rates.
- Understanding MCI's diagnosis, prognosis, and management is vital for future treatment development.
More Related Videos
Related Concept Videos
Cognitive Dissonance
Language and Cognition
Cognitive Therapy
Cognition and Behavior
Cognitive Learning
E. C. Tolman's theory of purposive behavior emphasizes that much behavior is goal-directed. He argued that to understand behavior, we must look at the entire sequence of actions leading to a goal. For instance, high school students study hard, not just due to past reinforcement but also to achieve the goal of getting into a good college.
Tolman introduced the idea that behavior is influenced by...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

